Literature DB >> 15287029

Mapping of a translocation breakpoint in a Peutz-Jeghers hamartoma to the putative PJS locus at 19q13.4 and mutation analysis of candidate genes in polyp and STK11-negative PJS cases.

Nicholas Hearle1, Anneke Lucassen, Rubin Wang, Wendy Lim, Fiona Ross, Robert Wheeler, Isabella Moore, Janet Shipley, Richard Houlston.   

Abstract

Germ-line mutations in the serine-threonine kinase gene STK11 (LKB1) cause Peutz-Jeghers syndrome (PJS), a rare autosomal dominantly inherited disease, characterized by hamartomatous polyposis and mucocutaneous pigmentation. STK11 mutations only account for about half of PJS cases, and a second disease locus has been proposed at chromosome segment 19q13.4 on the basis of genetic linkage analysis in one family. We identified a t(11;19)(q13;q13.4) in a PJS polyp arising from the small bowel in a female infant age 6 days. Because the breakpoint in 19q13.4 may disrupt the putative PJS disease gene mapping to this region, we mapped the breakpoint and analyzed DNA from the case and a series of STK11-negative PJS cases. Using two-color interphase fluorescence in situ hybridization, the breakpoint region was refined to a 0.5-Mb region within 19q13.4. Eight candidate genes mapping to the breakpoint region--U2AF2, EPN1, NALP4, NALP11, NALP5, ZNF444, PTPRH, and KIAA1811--were screened for mutations in germ-line and polyp DNA from the case and from 15 PJS cases that did not harbor germ-line STK11 mutations. No pathogenic mutations in the candidate genes were identified. This report provides further evidence of the existence of a second PJS disease locus at 19q13.4 and excludes involvement of eight candidate genes. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287029     DOI: 10.1002/gcc.20067

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

Review 1.  The lentiginoses: cutaneous markers of systemic disease and a window to new aspects of tumourigenesis.

Authors:  A J Bauer; C A Stratakis
Journal:  J Med Genet       Date:  2005-06-15       Impact factor: 6.318

2.  Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome.

Authors:  Hamid Mehenni; Nicoletta Resta; Ginevra Guanti; Louisa Mota-Vieira; Aaron Lerner; Mohammed Peyman; Kim A Chong; Larbi Aissa; Ali Ince; Angel Cosme; Michael C Costanza; Colette Rossier; Uppala Radhakrishna; Randall W Burt; Didier Picard
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

Review 3.  The differential diagnosis of familial lentiginosis syndromes.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

4.  Cancer risks in LKB1 germline mutation carriers.

Authors:  H Mehenni; N Resta; J-G Park; M Miyaki; G Guanti; M C Costanza
Journal:  Gut       Date:  2006-01-11       Impact factor: 23.059

5.  Genetic defects underlying Peutz-Jeghers syndrome (PJS) and exclusion of the polarity-associated MARK/Par1 gene family as potential PJS candidates.

Authors:  W W J de Leng; M Jansen; R Carvalho; M Polak; A R Musler; A N A Milne; J J Keller; F H Menko; F W M de Rooij; C A Iacobuzio-Donahue; F M Giardiello; M A J Weterman; G J A Offerhaus
Journal:  Clin Genet       Date:  2007-10-09       Impact factor: 4.438

6.  Mutation analysis of three genes encoding novel LKB1-interacting proteins, BRG1, STRADalpha, and MO25alpha, in Peutz-Jeghers syndrome.

Authors:  P Alhopuro; P Katajisto; R Lehtonen; S K Ylisaukko-Oja; L Näätsaari; A Karhu; A M Westerman; J H P Wilson; F W M de Rooij; T Vogel; G Moeslein; I P Tomlinson; L A Aaltonen; T P Mäkelä; V Launonen
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

7.  Clinical characteristics and STK11 gene mutations in Chinese children with Peutz-Jeghers syndrome.

Authors:  Zhiheng Huang; Shijian Miao; Lin Wang; Ping Zhang; Bingbing Wu; Jie Wu; Ying Huang
Journal:  BMC Gastroenterol       Date:  2015-11-25       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.